(19)
(11) EP 1 556 013 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
03.03.2010 Bulletin 2010/09

(45) Mention of the grant of the patent:
13.05.2009 Bulletin 2009/20

(21) Application number: 03769384.3

(22) Date of filing: 14.10.2003
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61P 39/04(2006.01)
 A61K 31/41(2006.01)
(86) International application number:
PCT/EP2003/011351
(87) International publication number:
WO 2004/035026 (29.04.2004 Gazette 2004/18)

(54)

DEFERASIROX DISPERSIBLE TABLETS

DEFERASIROX DISPERGIERBARE TABLETTE

COMPRIMES SOLUBLES DE DEFERASIROX

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 15.10.2002 GB 0223978

(43) Date of publication of application:
27.07.2005 Bulletin 2005/30

(73) Proprietors:
  • Novartis AG
    4056 Basel (CH)
    Designated Contracting States:
    TR BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK 
  • Novartis Pharma GmbH
    1230 Wien (AT)
    Designated Contracting States:
    AT 

(72) Inventors:
  • DEFFEZ, Karine
    F-69007 Lyon (FR)
  • CASSIERE, Jean-Pierre
    F-92500 Rueil Malmaison (FR)

(74) Representative: Roth, Peter Richard et al
Novartis AG Corporate Intellectual Property
4002 Basel
4002 Basel (CH)


(56) References cited: : 
EP-A- 1 070 496
WO-A-97/49395
 WO-A-00/57886
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).